|
CDK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.604600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.004800E-01 |
| Normal-vs-Stage2 |
4.660800E-01 |
| Normal-vs-Stage3 |
9.966800E-01 |
| Normal-vs-Stage4 |
7.509400E-01 |
| Stage1-vs-Stage2 |
9.077600E-03 |
| Stage1-vs-Stage3 |
1.454220E-01 |
| Stage1-vs-Stage4 |
5.550600E-01 |
| Stage2-vs-Stage3 |
2.911400E-01 |
| Stage2-vs-Stage4 |
2.086200E-01 |
| Stage3-vs-Stage4 |
6.678000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.503600E-01 |
| Normal-vs-AfricanAmerican |
8.644400E-01 |
| Normal-vs-Asian |
4.349800E-01 |
| Caucasian-vs-AfricanAmerican |
4.258400E-01 |
| Caucasian-vs-Asian |
6.835200E-01 |
| AfricanAmerican-vs-Asian |
3.274400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.709200E-01 |
| Normal-vs-Female |
7.558200E-01 |
| Male-vs-Female |
3.751800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.181000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.678800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.745200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.940200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.21079999999096E-05 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.182990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.950960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.811210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.180200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.981540E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.132600E-01 |
| Classical-VS-Follicular |
1.992370E-01 |
| Classical-VS-Other |
8.053400E-01 |
| Classical-VS-Normal |
5.017600E-01 |
| Tall-VS-Follicular |
5.803400E-01 |
| Tall-VS-Other |
9.093800E-01 |
| Tall-VS-Normal |
7.524000E-01 |
| Follicular-VS-Other |
8.483000E-01 |
| Follicular-VS-Normal |
9.348600E-01 |
| Other-VS-Normal |
8.817800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.792200E-01 |
| Normal-vs-N1 |
7.944000E-01 |
| N0-vs-N1 |
9.960800E-01 |
|
|
